HIV Disease Progression in the First Year after Delivery among African Women followed in the HPTN 046 Clinical Trial.

Publication Type:

Journal Article


Journal of acquired immune deficiency syndromes (1999) (2013)


2013, August 2013, Public Health Sciences Division, Vaccine and Infectious Disease Division


Starting lifelong antiretroviral therapy (ART) in HIV-infected pregnant women may decrease HIV progression and transmission but adherence after delivery may be difficult, especially for asymptomatic women. We evaluated disease progression among HIV-infected women not on ART with CD4+ lymphocyte counts above 200 cells/uL at delivery.